Pini Orbach

Pini Orbach currently works at BioSight Ltd., as Chairman from 2016, Metabomed Ltd., as Director, PTC Therapeutics MP, Inc., as Director, Ayala Pharmaceuticals, Inc., as Director from 2023, Accelmed Ventures, as Head-Pharma & Life Science Division from 2014, Arkin Bio Ventures, as Managing Partner, and Arkin Capital, as Head-Pharma Division.
Dr. Orbach also formerly worked at CyToD Ltd., as Chief Executive Officer, NanoDoc Biotechnology Ltd., as Chief Executive Officer, Sol-Gel Technologies Ltd., as Director, HealOr Ltd., as Director, cCAM Biotherapeutics Ltd., as Director, Quiet Therapeutics Ltd., as Director, UroGen Pharma Ltd., as Director from 2014 to 2018, Metallo Therapy Ltd., as Director from 2011 to 2015, and Pi Therapeutics Ltd., as Director.
Dr. Orbach received his doctorate degree from the University of Florida.